Cancer Institute A national cancer institute
designated cancer center

Neyssa Marina

Publication Details

  • Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumors.

    Marina NM, Rodman JH, Murry DJ, Shema SJ, Bowman LC, Jones DP, Furman W, Meyer WH, Pratt CB. J Natl Cancer Inst. 1994; 86 (7): 544-8

    The combination of carboplatin, ifosfamide, and etoposide has shown promising activity in a variety of relapsed childhood solid tumors but has not been studied in newly diagnosed patients.

    PubMedID: 8133538

Stanford Medicine Resources:

Footer Links: